ARVO 2025 presentation: Human cornea-on-a-chip – opportunities and challenges
Cornea is a tight barrier restricting topically administered drugs’ penetration into the eye. The aim of the study was to create a tight epithelial barrier both with primary and with transformed human corneal cells on a 96-well microfluidic platform.
Learn more